1. Lü, YiQing, Cho, Tiffany, Mukherjee, Saptaparna, Durocher, Daniel, Schramek, Daniel. 2024. Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. In Molecular systems biology, 20, 719-740. doi:10.1038/s44320-024-00032-x. https://pubmed.ncbi.nlm.nih.gov/38580884/
2. Sharma, Abhishek Bharadwaj, Ramlee, Muhammad Khairul, Kosmin, Joel, Gibbs-Seymour, Ian, Lakin, Nicholas D. 2023. C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption. In Nature communications, 14, 5003. doi:10.1038/s41467-023-40779-9. https://pubmed.ncbi.nlm.nih.gov/37591890/
3. Li, Dongxiao, Wang, Min. 2024. An LRPPRC-HAPSTR1-PSMD14 interaction regulates tumor progression in ovarian cancer. In Aging, 16, 6773-6795. doi:10.18632/aging.205713. https://pubmed.ncbi.nlm.nih.gov/38643468/
4. Amici, David R, Ansel, Daniel J, Metz, Kyle A, Li, Jian, Mendillo, Marc L. 2022. C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. In Proceedings of the National Academy of Sciences of the United States of America, 119, e2111262119. doi:10.1073/pnas.2111262119. https://pubmed.ncbi.nlm.nih.gov/35776542/
5. Benslimane, Yahya, Sánchez-Osuna, María, Coulombe-Huntington, Jasmin, Tyers, Mike, Harrington, Lea. 2021. A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. In Aging cell, 20, e13331. doi:10.1111/acel.13331. https://pubmed.ncbi.nlm.nih.gov/33660365/